跳至主要内容
临床试验/NCT01196312
NCT01196312已完成不适用

Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users

University of Maryland, College Park2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Anxiety Sensitivity Index-3

研究概览

简要总结

Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • exhibit a score of 21 on a self-report measure of anxiety sensitivity
  • be in 28 days of residential substance use treatment.
  • meet criteria for current opioid dependence as determined by SCID interview administered at intake.

排除标准

  • evidence of limited mental competency
  • the inability to give informed, voluntary, written consent to participate
  • current psychosis
  • current bipolar disorder.

结局指标

主要结局

Anxiety Sensitivity Index-3

时间窗: 24 weeks

次要结局

  • Timeline Follow Back 90 days(24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joe Smith

Director - HRPP (C. Lejuez is no longer at UMD)

University of Maryland, College Park

研究点 (2)

Loading locations...

相似试验